The best-laid plans go oft awry: Synaptogenic growth factor signaling in neuropsychiatric disease

Frontiers in Synaptic Neuroscience

Volumn 6, Issue MAR, 2014, Pages

  Williams, Aislinn J ^a,b   Umemori, Hisashi ^b,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Growth factor; Mental illness; Psychiatry; Synapse; Synaptogenesis

Indexed keywords

BETA CATENIN; BRAIN DERIVED NEUROTROPHIC FACTOR; DISHEVELLED 1; FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR 22; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GROWTH FACTOR; INOSITOL PHOSPHATE; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RETINOID RELATED ORPHAN RECEPTOR ALPHA; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; WNT1 PROTEIN; WNT2 PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN; WNT7A PROTEIN; WNT7B PROTEIN;

ACROCEPHALOSYNDACTYLY; ACTIN FILAMENT; CELL POLARITY; CIRCADIAN RHYTHM; DEPRESSION; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM; HUMAN; INTELLECTUAL IMPAIRMENT; INTRACELLULAR SIGNALING; MENTAL DISEASE; MOOD DISORDER; NERVE CELL; NEUROLOGIC DISEASE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PSYCHOSIS; RETT SYNDROME; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SUBSTANCE ABUSE; SYNAPTOGENESIS; WNT SIGNALING PATHWAY;

EID: 84904767138     PISSN: None     EISSN: 16633563     Source Type: Journal    
DOI: 10.3389/fnsyn.2014.00004     Document Type: Review

References (285)

1. Ades, L. C., Sullivan, K., Biggin, A., Haan, E. A., Brett, M., Holman, K. J., et al. (2006). FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited. Am. J. Med. Genet. A 140, 1047-1058. doi: 10.1002/ajmg.a.31202
2. Agis-Balboa, R. C., Arcos-Diaz, D., Wittnam, J., Govindarajan, N., Blom, K., Burkhardt, S., et al. (2011). A hippocampal insulin-growth factor 2 pathway regulates the extinction of fear memories. EMBO J. 30, 4071-4083. doi: 10.1038/emboj.2011.293
3. Ahmad-Annuar, A., Ciani, L., Simeonidis, I., Herreros, J., Fredj, N. B., Rosso, S. B., et al. (2006). Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release. J. Cell Biol. 174, 127-139. doi: 10.1083/jcb.200511054
4. Aliashkevich, A. F., Yilmazer-Hanke, D., Van Roost, D., Mundhenk, B., Schramm, J., and Blumcke, I. (2003). Cellular pathology of amygdala neurons in human temporal lobe epilepsy. Acta Neuropathol. 106, 99-106. doi: 10.1007/s00401-003-0707-0
5. Alsmadi, O., Meyer, B. F., Alkuraya, F., Wakil, S., Alkayal, F., Al-Saud, H., et al. (2009). Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3). Eur. J. Hum. Genet. 17, 14-21. doi: 10.1038/ejhg.2008.141
6. Andreassen, O. A., Djurovic, S., Thompson, W. K., Schork, A. J., Kendler, K. S., O'donovan, M. C., et al. (2013). Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am. J. Hum. Genet. 92, 197-209. doi: 10.1016/j.ajhg.2013.01.001
7. Arauz, R. F., Solomon, B. D., Pineda-Alvarez, D. E., Gropman, A. L., Parsons, J. A., Roessler, E., et al. (2010). A hypomorphic allele in the FGF8 gene contributes to holoprosencephaly and is allelic to gonadotropin-releasing hormone deficiency in humans. Mol. Syndromol. 1, 59-66. doi: 10.1159/000302285
8. Arnaldez, F. I., and Helman, L. J. (2012). Targeting the insulin growth factor receptor 1. Hematol. Oncol. Clin. North Am. 26, 527-542, vii-viii. doi: 10.1016/j.hoc.2012.01.004
9. Association, A. P. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th Edn. Arlington, VA: American Psychiatric Publishing.
10. Babic, M., and Zinsmaier, K. E. (2011). Memory, synapse stability, and beta-adducin. Neuron 69, 1039-1041. doi: 10.1016/j.neuron.2011.03.004
11. Baldini, S., Restani, L., Baroncelli, L., Coltelli, M., Franco, R., Cenni, M. C., et al. (2013). Enriched early life experiences reduce adult anxiety-like behavior in rats: a role for insulin-like growth factor 1. J. Neurosci. 33, 11715-11723. doi: 10.1523/JNEUROSCI.3541-12.2013
12. Barros, C. S., Calabrese, B., Chamero, P., Roberts, A. J., Korzus, E., Lloyd, K., et al. (2009). Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 106, 4507-4512. doi: 10.1073/pnas.0900355106
13. Bartke, A. (2008). Insulin and aging. Cell Cycle 7, 3338-3343. doi: 10.4161/cc.7.21.7012
14. Beenken, A., and Mohammadi, M. (2009). The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235-253. doi: 10.1038/nrd2792
15. Bendall, S. C., Stewart, M. H., Menendez, P., George, D., Vijayaragavan, K., Werbowetski-Ogilvie, T., et al. (2007). IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448, 1015-1021. doi: 10.1038/nature06027
16. Benito, E., and Barco, A. (2010). CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models. Trends Neurosci. 33, 230-240. doi: 10.1016/j.tins.2010.02.001
17. Bennett, M. R., and Lagopoulos, J. (2014). Stress and trauma: BDNF control of dendritic-spine formation and regression. Prog. Neurobiol. 112, 80-99. doi: 10.1016/j.pneurobio.2013.10.005
18. Bikkavilli, R. K., Feigin, M. E., and Malbon, C. C. (2008). p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta. J. Cell Sci. 121, 3598-3607. doi: 10.1242/jcs.032854
19. Blakely, B. D., Bye, C. R., Fernando, C. V., Prasad, A. A., Pasterkamp, R. J., Macheda, M. L., et al. (2013). Ryk, a receptor regulating Wnt5a-mediated neurogenesis and axon morphogenesis of ventral midbrain dopaminergic neurons. Stem Cells Dev. 22, 2132-2144. doi: 10.1089/scd.2013.0066
20. Bondy, C. A. (1991). Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J. Neurosci. 11, 3442-3455.
21. Bondy, C. A., and Cheng, C. M. (2004). Signaling by insulin-like growth factor 1 in brain. Eur. J. Pharmacol. 490, 25-31. doi: 10.1016/j.ejphar.2004.02.042
22. Bookout, A. L., De Groot, M. H., Owen, B. M., Lee, S., Gautron, L., Lawrence, H. L., et al. (2013). FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat. Med. 19, 1147-1152. doi: 10.1038/nm.3249
23. Boucher, T. J., Okuse, K., Bennett, D. L., Munson, J. B., Wood, J. N., and McMahon, S. B. (2000). Potent analgesic effects of GDNF in neuropathic pain states. Science 290, 124-127. doi: 10.1126/science.290.5489.124
24. Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., et al. (2011). Modelling schizophrenia using human induced pluripotent stem cells. Nature 473, 221-225. doi: 10.1038/nature09915
25. Brionne, T. C., Tesseur, I., Masliah, E., and Wyss-Coray, T. (2003). Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40, 1133-1145. doi: 10.1016/S0896-6273(03)00766-9
26. Bryant, M. R., Marta, C. B., Kim, F. S., and Bansal, R. (2009). Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes. Glia 57, 935-946. doi: 10.1002/glia.20818
27. Bulow, B., Hagmar, L., Orbaek, P., Osterberg, K., and Erfurth, E. M. (2002). High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease. Clin. Endocrinol. (Oxf.) 56, 183-193. doi: 10.1046/j.0300-0664.2001.01461.x
28. Cao, L., Jiao, X., Zuzga, D. S., Liu, Y., Fong, D. M., Young, D., et al. (2004). VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. Genet. 36, 827-835. doi: 10.1038/ng1395
29. Carnicella, S., Kharazia, V., Jeanblanc, J., Janak, P. H., and Ron, D. (2008). GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proc. Natl. Acad. Sci. U.S.A. 105, 8114-8119. doi: 10.1073/pnas.0711755105
30. Carvalho, O. P., Thornton, G. K., Hertecant, J., Houlden, H., Nicholas, A. K., Cox, J. J., et al. (2011). A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J. Med. Genet. 48, 131-135. doi: 10.1136/jmg.2010.081455
31. Chalecka-Franaszek, E., and Chuang, D. M. (1999). Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl. Acad. Sci. U.S.A. 96, 8745-8750.
32. Chattopadhyay, A., and Carpenter, G. (2002). PLC-gamma1 is required for IGF-I protection from cell death induced by loss of extracellular matrix adhesion. J. Cell Sci. 115, 2233-2239.
33. Chen, B., Brinkmann, K., Chen, Z., Pak, C. W., Liao, Y., Shi, S., et al. (2014). The WAVE regulatory complex links diverse receptors to the actin cytoskeleton. Cell 156, 195-207. doi: 10.1016/j.cell.2013.11.048
34. Chen, D. Y., Stern, S. A., Garcia-Osta, A., Saunier-Rebori, B., Pollonini, G., Bambah-Mukku, D., et al. (2011). A critical role for IGF-II in memory consolidation and enhancement. Nature 469, 491-497. doi: 10.1038/nature09667
35. Chen, J., Park, C. S., and Tang, S. J. (2006a). Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J. Biol. Chem. 281, 11910-11916. doi: 10.1074/jbc.M511920200
36. Chen, Z. Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C. J., et al. (2006b). Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314, 140-143. doi: 10.1126/science.1129663
37. Chia, P. H., Chen, B., Li, P., Rosen, M. K., and Shen, K. (2014). Local F-actin network links synapse formation and axon branching. Cell 156, 208-220. doi: 10.1016/j.cell.2013.12.009
38. Cholfin, J. A., and Rubenstein, J. L. (2007). Patterning of frontal cortex subdivisions by Fgf17. Proc. Natl. Acad. Sci. U.S.A. 104, 7652-7657. doi: 10.1073/pnas.0702225104
39. Chung, K., Wallace, J., Kim, S. Y., Kalyanasundaram, S., Andalman, A. S., Davidson, T. J., et al. (2013). Structural and molecular interrogation of intact biological systems. Nature 497, 332-337. doi: 10.1038/nature12107
40. Ciani, L., Boyle, K. A., Dickins, E., Sahores, M., Anane, D., Lopes, D. M., et al. (2011). Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca(2)(+)/Calmodulin-dependent protein kinase II. Proc. Natl. Acad. Sci. U.S.A. 108, 10732-10737. doi: 10.1073/pnas.1018132108
41. Clarimon, J., Xiromerisiou, G., Eerola, J., Gourbali, V., Hellstrom, O., Dardiotis, E., et al. (2005). Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients. BMC Neurol. 5:11. doi: 10.1186/1471-2377-5-11
42. Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G., and Ornitz, D. M. (1996). Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12, 390-397. doi: 10.1038/ng0496-390
43. Corvin, A. P., Molinos, I., Little, G., Donohoe, G., Gill, M., Morris, D. W., et al. (2012). Insulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms. Neurosci. Lett. 520, 51-56. doi: 10.1016/j.neulet.2012.05.029
44. Cosgaya, J. M., Chan, J. R., and Shooter, E. M. (2002). The neurotrophin receptor p75NTR as a positive modulator of myelination. Science 298, 1245-1248. doi: 10.1126/science.1076595
45. Counts, S. E., Nadeem, M., Wuu, J., Ginsberg, S. D., Saragovi, H. U., and Mufson, E. J. (2004). Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann. Neurol. 56, 520-531. doi: 10.1002/ana.20233
46. Cross-Disorder Group of the Psychiatric Genomics, C., Smoller, J. W., Craddock, N., Kendler, K., Lee, P. H., Neale, B. M., et al. (2013). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379. doi: 10.1016/S0140-6736(12)62129-1
47. Cui, H., Meng, Y., and Bulleit, R. F. (1998). Inhibition of glycogen synthase kinase 3beta activity regulates proliferation of cultured cerebellar granule cells. Brain Res. Dev. Brain Res. 111, 177-188.
48. Davis, E. K., Zou, Y., and Ghosh, A. (2008). Wnts acting through canonical and noncanonical signaling pathways exert opposite effects on hippocampal synapse formation. Neural Dev. 3, 32. doi: 10.1186/1749-8104-3-32
49. De, A. (2011). Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochim. Biophys. Sin. (Shanghai). 43, 745-756. doi: 10.1093/abbs/gmr079
50. De Ligt, J., Willemsen, M. H., Van Bon, B. W., Kleefstra, T., Yntema, H. G., Kroes, T., et al. (2012). Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367, 1921-1929. doi: 10.1056/NEJMoa1206524
51. Dode, C., Levilliers, J., Dupont, J. M., De Paepe, A., Le Du, N., Soussi-Yanicostas, N., et al. (2003). Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat. Genet. 33, 463-465. doi: 10.1038/ng1122
52. Doniach, T. (1995). Basic FGF as an inducer of anteroposterior neural pattern. Cell 83, 1067-1070.
53. Dono, R. (2003). Fibroblast growth factors as regulators of central nervous system development and function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R867-R881. doi: 10.1152/ajpregu.00533.2002
54. Dono, R., Texido, G., Dussel, R., Ehmke, H., and Zeller, R. (1998). Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J. 17, 4213-4225. doi: 10.1093/emboj/17.15.4213
55. Easton, J. B., Moody, N. M., Zhu, X., and Middlemas, D. S. (1999). Brain-derived neurotrophic factor induces phosphorylation of fibroblast growth factor receptor substrate 2. J. Biol. Chem. 274, 11321-11327.
56. Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269. doi: 10.1016/S0092-8674(03)00035-7
57. Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., and Gogos, J. A. (2004). Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 36, 131-137. doi: 10.1038/ng1296
58. Eren-Kocak, E., Turner, C. A., Watson, S. J., and Akil, H. (2011). Short-hairpin RNA silencing of endogenous fibroblast growth factor 2 in rat hippocampus increases anxiety behavior. Biol. Psychiatry 69, 534-540. doi: 10.1016/j.biopsych.2010.11.020
59. Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., et al. (2004). Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. U.S.A. 101, 15506-15511. doi: 10.1073/pnas.0406788101
60. Fagan, A. M., Garber, M., Barbacid, M., Silos-Santiago, I., and Holtzman, D. M. (1997). A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo. J. Neurosci. 17, 7644-7654.
61. Falardeau, J., Chung, W. C., Beenken, A., Raivio, T., Plummer, L., Sidis, Y., et al. (2008). Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J. Clin. Invest. 118, 2822-2831. doi: 10.1172/JCI34538
62. Farhadi, H. F., Mowla, S. J., Petrecca, K., Morris, S. J., Seidah, N. G., and Murphy, R. A. (2000). Neurotrophin-3 sorts to the constitutive secretory pathway of hippocampal neurons and is diverted to the regulated secretory pathway by coexpression with brain-derived neurotrophic factor. J. Neurosci. 20, 4059-4068.
63. Fernandez, A. M., and Torres-Aleman, I. (2012). The many faces of insulin-like peptide signalling in the brain. Nat. Rev. Neurosci. 13, 225-239. doi: 10.1038/nrn3209
64. Fiorentino, H., Kuczewski, N., Diabira, D., Ferrand, N., Pangalos, M. N., Porcher, C., et al. (2009). GABA(B) receptor activation triggers BDNF release and promotes the maturation of GABAergic synapses. J. Neurosci. 29, 11650-11661. doi: 10.1523/JNEUROSCI.3587-09.2009
65. Flajolet, M., Wang, Z., Futter, M., Shen, W., Nuangchamnong, N., Bendor, J., et al. (2008). FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity. Nat. Neurosci. 11, 1402-1409. doi: 10.1038/nn.2216
66. Fortress, A. M., Schram, S. L., Tuscher, J. J., and Frick, K. M. (2013). Canonical Wnt signaling is necessary for object recognition memory consolidation. J. Neurosci. 33, 12619-12626. doi: 10.1523/JNEUROSCI.0659-13.2013
67. Fox, M. A., Sanes, J. R., Borza, D. B., Eswarakumar, V. P., Fassler, R., Hudson, B. G., et al. (2007). Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals. Cell 129, 179-193. doi: 10.1016/j.cell.2007.02.035
68. Francomano, C. A., McIntosh, I., and Wilkin, D. J. (1996). Bone dysplasias in man: molecular insights. Curr. Opin. Genet. Dev. 6, 301-308.
69. Frenz, D. A., Liu, W., Cvekl, A., Xie, Q., Wassef, L., Quadro, L., et al. (2010). Retinoid signaling in inner ear development: a "Goldilocks" phenomenon. Am. J. Med. Genet. A 152A, 2947-2961. doi: 10.1002/ajmg.a.33670
70. Fukuchi-Shimogori, T., and Grove, E. A. (2001). Neocortex patterning by the secreted signaling molecule FGF8. Science 294, 1071-1074. doi: 10.1126/science.1064252
71. Garcia-Segura, L. M., Perez, J., Pons, S., Rejas, M. T., and Torres-Aleman, I. (1991). Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain. Brain Res. 560, 167-174.
72. Garcia-Segura, L. M., Rodriguez, J. R., and Torres-Aleman, I. (1997). Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: an electron microscopic study. J. Neurocytol. 26, 479-490.
73. Garcia-Vargas, A., Hafner, C., Perez-Rodriguez, A. G., Rodriguez-Rojas, L. X., Gonzalez-Esqueda, P., Stoehr, R., et al. (2008). An epidermal nevus syndrome with cerebral involvement caused by a mosaic FGFR3 mutation. Am. J. Med. Genet. A 146A, 2275-2279. doi: 10.1002/ajmg.a.32429
74. Geller, B., Badner, J. A., Tillman, R., Christian, S. L., Bolhofner, K., and Cook, E. H. Jr. (2004). Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry 161, 1698-1700. doi: 10.1176/appi.ajp.161.9.1698
75. Gigante, A. D., Young, L. T., Yatham, L. N., Andreazza, A. C., Nery, F. G., Grinberg, L. T., et al. (2011). Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int. J. Neuropsychopharmacol. 14, 1075-1089. doi: 10.1017/S146114571000146X
76. Gogolla, N., Galimberti, I., Deguchi, Y., and Caroni, P. (2009). Wnt signaling mediates experience-related regulation of synapse numbers and mossy fiber connectivities in the adult hippocampus. Neuron 62, 510-525. doi: 10.1016/j.neuron.2009.04.022
77. Gould, T. D., O'donnell, K. C., Picchini, A. M., Dow, E. R., Chen, G., and Manji, H. K. (2008). Generation and behavioral characterization of beta-catenin forebrain-specific conditional knock-out mice. Behav. Brain Res. 189, 117-125. doi: 10.1016/j.bbr.2007.12.028
78. Gripp, K. W., Stolle, C. A., McDonald-McGinn, D. M., Markowitz, R. I., Bartlett, S. P., Katowitz, J. A., et al. (1998). Phenotype of the fibroblast growth factor receptor 2 Ser351Cys mutation: Pfeiffer syndrome type III. Am. J. Med. Genet. 78, 356-360.
79. Guillemot, F., and Zimmer, C. (2011). From cradle to grave: the multiple roles of fibroblast growth factors in neural development. Neuron 71, 574-588. doi: 10.1016/j.neuron.2011.08.002
80. Guilmatre, A., Huguet, G., Delorme, R., and Bourgeron, T. (2014). The emerging role of SHANK genes in neuropsychiatric disorders. Dev. Neurobiol. 74, 113-122. doi: 10.1002/dneu.22128
81. Gunhaga, L., Marklund, M., Sjodal, M., Hsieh, J. C., Jessell, T. M., and Edlund, T. (2003). Specification of dorsal telencephalic character by sequential Wnt and FGF signaling. Nat. Neurosci. 6, 701-707. doi: 10.1038/nn1068
82. Hall, A. C., Brennan, A., Goold, R. G., Cleverley, K., Lucas, F. R., Gordon-Weeks, P. R., et al. (2002). Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol. Cell. Neurosci. 20, 257-270. doi: 10.1006/mcne.2002.1117
83. Hall, A. C., Lucas, F. R., and Salinas, P. C. (2000). Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 100, 525-535. doi: 10.1016/S0092-8674(00)80689-3
84. Hall, D., Dhilla, A., Charalambous, A., Gogos, J. A., and Karayiorgou, M. (2003). Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am. J. Hum. Genet. 73, 370-376. doi: 10.1086/377003
85. Han, J. C., Liu, Q. R., Jones, M., Levinn, R. L., Menzie, C. M., Jefferson-George, K. S., et al. (2008). Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N. Engl. J. Med. 359, 918-927. doi: 10.1056/NEJMoa0801119
86. Hedgepeth, C. M., Conrad, L. J., Zhang, J., Huang, H. C., Lee, V. M., and Klein, P. S. (1997). Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol. 185, 82-91. doi: 10.1006/dbio.1997.8552
87. Hensler, J. G., Ladenheim, E. E., and Lyons, W. E. (2003). Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF (+/-) mice. J. Neurochem. 85, 1139-1147. doi: 10.1046/j.1471-4159.2003.01748.x
88. Hoeffer, C. A., and Klann, E. (2010). mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75. doi: 10.1016/j.tins.2009.11.003
89. Hollway, G. E., Suthers, G. K., Battese, K. M., Turner, A. M., David, D. J., and Mulley, J. C. (1998). Deafness due to Pro250Arg mutation of FGFR3. Lancet 351, 877-878. doi: 10.1016/S0140-6736(98)24012-8
90. Hong, E. J., McCord, A. E., and Greenberg, M. E. (2008). A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition. Neuron 60, 610-624. doi: 10.1016/j.neuron.2008.09.024
91. Houart, C., Caneparo, L., Heisenberg, C., Barth, K., Take-Uchi, M., and Wilson, S. (2002). Establishment of the telencephalon during gastrulation by local antagonism of Wnt signaling. Neuron 35, 255-265. doi: 10.1016/S0896-6273(02)00751-1
92. Hu, Y. S., Long, N., Pigino, G., Brady, S. T., and Lazarov, O. (2013). Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3beta, neurotrophin-3 and CREB signaling. PLoS ONE 8:e64460. doi: 10.1371/journal.pone.0064460
93. Huang, W., Zhao, Y., Zhu, X., Cai, Z., Wang, S., Yao, S., et al. (2013). Fluoxetine upregulates phosphorylated-AKT and phosphorylated-ERK1/2 proteins in neural stem cells: evidence for a crosstalk between AKT and ERK1/2 pathways. J. Mol. Neurosci. 49, 244-249. doi: 10.1007/s12031-012-9822-5
94. Iki, J., Inoue, A., Bito, H., and Okabe, S. (2005). Bi-directional regulation of postsynaptic cortactin distribution by BDNF and NMDA receptor activity. Eur. J. Neurosci. 22, 2985-2994. doi: 10.1111/j.1460-9568.2005.04510.x
95. Irving, C., Malhas, A., Guthrie, S., and Mason, I. (2002). Establishing the trochlear motor axon trajectory: role of the isthmic organiser and Fgf8. Development 129, 5389-5398. doi: 10.1242/dev.00117
96. Issa, G., Wilson, C., Terry, A. V. Jr., and Pillai, A. (2010). An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiol. Dis. 39, 327-333. doi: 10.1016/j.nbd.2010.04.017
97. Itami, C., Mizuno, K., Kohno, T., and Nakamura, S. (2000). Brain-derived neurotrophic factor requirement for activity-dependent maturation of glutamatergic synapse in developing mouse somatosensory cortex. Brain Res. 857, 141-150. doi: 10.1016/S0006-8993(99)02352-5
98. Ito, J., Nagayasu, Y., Hoshikawa, M., Kato, K. H., Miura, Y., Asai, K., et al. (2013). Enhancement of FGF-1 release along with cytosolic proteins from rat astrocytes by hydrogen peroxide. Brain Res. 1522, 12-21. doi: 10.1016/j.brainres.2013.05.035
99. Jeanblanc, J., He, D. Y., McGough, N. N., Logrip, M. L., Phamluong, K., Janak, P. H., et al. (2006). The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption. J. Neurosci. 26, 1457-1464. doi: 10.1523/JNEUROSCI.3786-05.2006
100. Jeffers, M., Shimkets, R., Prayaga, S., Boldog, F., Yang, M., Burgess, C., et al. (2001). Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis. Cancer Res. 61, 3131-3138.
101. Johnson, E. M., Craig, E. T., and Yeh, H. H. (2007). TrkB is necessary for pruning at the climbing fibre-Purkinje cell synapse in the developing murine cerebellum. J. Physiol. 582, 629-646. doi: 10.1113/jphysiol.2007.133561
102. Johnson-Venkatesh, E. M., and Umemori, H. (2010). Secreted factors as synaptic organizers. Eur. J. Neurosci. 32, 181-190. doi: 10.1111/j.1460-9568.2010.07338.x
103. Kang, H., Sun, L. D., Atkins, C. M., Soderling, T. R., Wilson, M. A., and Tonegawa, S. (2001). An important role of neural activity-dependent CaMKIV signaling in the consolidation of long-term memory. Cell 106, 771-783. doi: 10.1016/S0092-8674(01)00497-4
104. Kenny, E. M., Cormican, P., Furlong, S., Heron, E., Kenny, G., Fahey, C., et al. (2013). Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol. Psychiatry. doi: 10.1038/mp.2013.127. [Epub ahead of print].
105. Kenyon, C. J. (2010). The genetics of ageing. Nature 464, 504-512. doi: 10.1038/nature08980
106. Kim, H., Won, S., Hwang, D. Y., Lee, J. S., Kim, M., Kim, R., et al. (2011). Downregulation of Wnt/beta-catenin signaling causes degeneration of hippocampal neurons in vivo. Neurobiol. Aging 32, 2316.e1-2316.e15. doi: 10.1016/j.neurobiolaging.2010.03.013
107. Kitagishi, Y., Kobayashi, M., Kikuta, K., and Matsuda, S. (2012). Roles of PI3K/AKT/GSK3/mTOR pathway in cell signaling of mental illnesses. Depress. Res. Treat. 2012:752563. doi: 10.1155/2012/752563
108. Klint, P., and Claesson-Welsh, L. (1999). Signal transduction by fibroblast growth factor receptors. Front. Biosci. 4, D165-D177. doi: 10.2741/Klint
109. Kramer, A., Yang, F. C., Snodgrass, P., Li, X., Scammell, T. E., Davis, F. C., et al. (2001). Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science 294, 2511-2515. doi: 10.1126/science.1067716
110. Kratochwil, K., Galceran, J., Tontsch, S., Roth, W., and Grosschedl, R. (2002). FGF4, a direct target of LEF1 and Wnt signaling, can rescue the arrest of tooth organogenesis in Lef1(-/-) mice. Genes Dev. 16, 3173-3185. doi: 10.1101/gad.1035602
111. Krieglstein, K., Zheng, F., Unsicker, K., and Alzheimer, C. (2011). More than being protective: functional roles for TGF-beta/activin signaling pathways at central synapses. Trends Neurosci. 34, 421-429. doi: 10.1016/j.tins.2011.06.002
112. Krylova, O., Herreros, J., Cleverley, K. E., Ehler, E., Henriquez, J. P., Hughes, S. M., et al. (2002). WNT-3, expressed by motoneurons, regulates terminal arborization of neurotrophin-3-responsive spinal sensory neurons. Neuron 35, 1043-1056. doi: 10.1016/S0896-6273(02)00860-7
113. Kurian, M. A., Meyer, E., Vassallo, G., Morgan, N. V., Prakash, N., Pasha, S., et al. (2010). Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. Brain 133, 2964-2970. doi: 10.1093/brain/awq238
114. Ladher, R. K., Anakwe, K. U., Gurney, A. L., Schoenwolf, G. C., and Francis-West, P. H. (2000). Identification of synergistic signals initiating inner ear development. Science 290, 1965-1967. doi: 10.1126/science.290.5498.1965
115. Lai, K. O., Wong, A. S., Cheung, M. C., Xu, P., Liang, Z., Lok, K. C., et al. (2012). TrkB phosphorylation by Cdk5 is required for activity-dependent structural plasticity and spatial memory. Nat. Neurosci. 15, 1506-1515. doi: 10.1038/nn.3237
116. Lako, M., Lindsay, S., Bullen, P., Wilson, D. I., Robson, S. C., and Strachan, T. (1998). A novel mammalian wnt gene, WNT8B, shows brain-restricted expression in early development, with sharply delimited expression boundaries in the developing forebrain. Hum. Mol. Genet. 7, 813-822.
117. Larimore, J. L., Chapleau, C. A., Kudo, S., Theibert, A., Percy, A. K., and Pozzo-Miller, L. (2009). Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol. Dis. 34, 199-211. doi: 10.1016/j.nbd.2008.12.011
118. Lee, C. H., Javed, D., Althaus, A. L., Parent, J. M., and Umemori, H. (2012). Neurogenesis is enhanced and mossy fiber sprouting arises in FGF7-deficient mice during development. Mol. Cell. Neurosci. 51, 61-67. doi: 10.1016/j.mcn.2012.07.010
119. Lee, C. H., and Umemori, H. (2013). Suppression of epileptogenesis-associated changes in response to seizures in FGF22-deficient mice. Front. Cell. Neurosci. 7:43. doi: 10.3389/fncel.2013.00043
120. Le-Niculescu, H., Patel, S. D., Bhat, M., Kuczenski, R., Faraone, S. V., Tsuang, M. T., et al. (2009). Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 155-181. doi: 10.1002/ajmg.b.30887
121. Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science 237, 1154-1162.
122. Li, A. J., Suzuki, S., Suzuki, M., Mizukoshi, E., and Imamura, T. (2002). Fibroblast growth factor-2 increases functional excitatory synapses on hippocampal neurons. Eur. J. Neurosci. 16, 1313-1324. doi: 10.1046/j.1460-9568.2002.02193.x
123. Li, E., Kim, D. H., Cai, M., Lee, S., Kim, Y., Lim, E., et al. (2011). Hippocampus-dependent spatial learning and memory are impaired in growth hormone-deficient spontaneous dwarf rats. Endocr. J. 58, 257-267. doi: 10.1507/endocrj.K11E-006
124. Li, Z., and Thiele, C. J. (2007). Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway. Expert Opin. Ther. Targets 11, 1611-1621. doi: 10.1517/14728222.11.12.1611
125. Lichtenstein, P., Carlstrom, E., Rastam, M., Gillberg, C., and Anckarsater, H. (2010). The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am. J. Psychiatry 167, 1357-1363. doi: 10.1176/appi.ajp.2010.10020223
126. Lie, D. C., Colamarino, S. A., Song, H. J., Desire, L., Mira, H., Consiglio, A., et al. (2005). Wnt signalling regulates adult hippocampal neurogenesis. Nature 437, 1370-1375. doi: 10.1038/nature04108
127. Lijam, N., Paylor, R., McDonald, M. P., Crawley, J. N., Deng, C. X., Herrup, K., et al. (1997). Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90, 895-905.
128. Lilley, B. N., Pan, Y. A., and Sanes, J. R. (2013). SAD kinases sculpt axonal arbors of sensory neurons through long- and short-term responses to neurotrophin signals. Neuron 79, 39-53. doi: 10.1016/j.neuron.2013.05.017
129. Lin, T., Sandusky, S. B., Xue, H., Fishbein, K. W., Spencer, R. G., Rao, M. S., et al. (2003). A central nervous system specific mouse model for thanatophoric dysplasia type II. Hum. Mol. Genet. 12, 2863-2871. doi: 10.1093/hmg/ddg309
130. Liu, G., Gu, B., He, X. P., Joshi, R. B., Wackerle, H. D., Rodriguiz, R. M., et al. (2013). Transient inhibition of TrkB kinase after status epilepticus prevents development of temporal lobe epilepsy. Neuron 79, 31-38. doi: 10.1016/j.neuron.2013.04.027
131. Liu, R. J., Lee, F. S., Li, X. Y., Bambico, F., Duman, R. S., and Aghajanian, G. K. (2012). Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol. Psychiatry 71, 996-1005. doi: 10.1016/j.biopsych.2011.09.030
132. Liu, X., Ernfors, P., Wu, H., and Jaenisch, R. (1995). Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. Nature 375, 238-241. doi: 10.1038/375238a0
133. Loeys, B. L., Chen, J., Neptune, E. R., Judge, D. P., Podowski, M., Holm, T., et al. (2005). A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37, 275-281. doi: 10.1038/ng1511
134. Logue, M. W., Baldwin, C., Guffanti, G., Melista, E., Wolf, E. J., Reardon, A. F., et al. (2013). A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol. Psychiatry 18, 937-942. doi: 10.1038/mp.2012.113
135. Lucas, F. R., and Salinas, P. C. (1997). WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Dev. Biol. 192, 31-44. doi: 10.1006/dbio.1997.8734
136. Lynch, C. J., Uddin, L. Q., Supekar, K., Khouzam, A., Phillips, J., and Menon, V. (2013). Default mode network in childhood autism: posteromedial cortex heterogeneity and relationship with social deficits. Biol. Psychiatry 74, 212-219. doi: 10.1016/j.biopsych.2012.12.013
137. Lyons, W. E., Mamounas, L. A., Ricaurte, G. A., Coppola, V., Reid, S. W., Bora, S. H., et al. (1999). Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. U.S.A. 96, 15239-15244.
138. Ma, L., Harada, T., Harada, C., Romero, M., Hebert, J. M., McConnell, S. K., et al. (2002). Neurotrophin-3 is required for appropriate establishment of thalamocortical connections. Neuron 36, 623-634. doi: 10.1016/S0896-6273(02)01021-8
139. Macleod, R. J., Moores, M. E., and Beninger, R. J. (2012). Amphetamine stimulates Wnt3 increases in rat nucleus accumbens. Neuroreport 23, 846-850. doi: 10.1097/WNR.0b013e328357d868
140. Manji, H. K., Drevets, W. C., and Charney, D. S. (2001). The cellular neurobiology of depression. Nat. Med. 7, 541-547. doi: 10.1038/87865
141. Mardy, S., Miura, Y., Endo, F., Matsuda, I., Sztriha, L., Frossard, P., et al. (1999). Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor. Am. J. Hum. Genet. 64, 1570-1579. doi: 10.1086/302422
142. Margolis, R. L., Chuang, D. M., and Post, R. M. (1994). Programmed cell death: implications for neuropsychiatric disorders. Biol. Psychiatry 35, 946-956.
143. Markowska, A. L., Mooney, M., and Sonntag, W. E. (1998). Insulin-like growth factor-1 ameliorates age-related behavioral deficits. Neuroscience 87, 559-569.
144. Martin, D. J., and Smith, D. J. (2013). Is there a clinical prodrome of bipolar disorder? A review of the evidence. Expert Rev. Neurother. 13, 89-98. doi: 10.1586/ern.12.149
145. Martinez-Morales, J. R., Del Bene, F., Nica, G., Hammerschmidt, M., Bovolenta, P., and Wittbrodt, J. (2005). Differentiation of the vertebrate retina is coordinated by an FGF signaling center. Dev. Cell 8, 565-574. doi: 10.1016/j.devcel.2005.01.022
146. Mason, I. (2007). Initiation to end point: the multiple roles of fibroblast growth factors in neural development. Nat. Rev. Neurosci. 8, 583-596. doi: 10.1038/nrn2189
147. Mauceri, D., Freitag, H. E., Oliveira, A. M., Bengtson, C. P., and Bading, H. (2011). Nuclear calcium-VEGFD signaling controls maintenance of dendrite arborization necessary for memory formation. Neuron 71, 117-130. doi: 10.1016/j.neuron.2011.04.022
148. McCormack, K., Sanchez, M. M., Bardi, M., and Maestripieri, D. (2006). Maternal care patterns and behavioral development of rhesus macaque abused infants in the first 6 months of life. Dev. Psychobiol. 48, 537-550. doi: 10.1002/dev.20157
149. McCoy, P. A., Shao, Y., Wolpert, C. M., Donnelly, S. L., Ashley-Koch, A., Abel, H. L., et al. (2002). No association between the WNT2 gene and autistic disorder. Am. J. Med. Genet. 114, 106-109. doi: 10.1002/ajmg.10182
150. McFarlane, S., McNeill, L., and Holt, C. E. (1995). FGF signaling and target recognition in the developing Xenopus visual system. Neuron 15, 1017-1028.
151. McGough, N. N., He, D. Y., Logrip, M. L., Jeanblanc, J., Phamluong, K., Luong, K., et al. (2004). RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J. Neurosci. 24, 10542-10552. doi: 10.1523/JNEUROSCI.3714-04.2004
152. McGrath, C. L., Glatt, S. J., Sklar, P., Le-Niculescu, H., Kuczenski, R., Doyle, A. E., et al. (2009). Evidence for genetic association of RORB with bipolar disorder. BMC Psychiatry 9:70. doi: 10.1186/1471-244X-9-70
153. Mei, L., and Xiong, W. C. (2008). Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437-452. doi: 10.1038/nrn2392
154. Mennerick, S., and Zorumski, C. F. (2000). Neural activity and survival in the developing nervous system. Mol. Neurobiol. 22, 41-54. doi: 10.1385/MN:22:1-3:041
155. Messer, C. J., Eisch, A. J., Carlezon, W. A. Jr., Whisler, K., Shen, L., Wolf, D. H., et al. (2000). Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26, 247-257. doi: 10.1016/S0896-6273(00)81154-X
156. Meyer, R. M., Burgos-Robles, A., Liu, E., Correia, S. S., and Goosens, K. A. (2013). A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear. Mol. Psychiatry. doi: 10.1038/mp.2013.135. [Epub ahead of print].
157. Meyer-Franke, A., Kaplan, M. R., Pfrieger, F. W., and Barres, B. A. (1995). Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 15, 805-819.
158. Meyers, E. N., Lewandoski, M., and Martin, G. R. (1998). An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18, 136-141. doi: 10.1038/ng0298-136
159. Minichiello, L. (2009). TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci. 10, 850-860. doi: 10.1038/nrn2738
160. Minichiello, L., Korte, M., Wolfer, D., Kuhn, R., Unsicker, K., Cestari, V., et al. (1999). Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24, 401-414.
161. Miraoui, H., Dwyer, A. A., Sykiotis, G. P., Plummer, L., Chung, W., Feng, B., et al. (2013). Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am. J. Hum. Genet. 92, 725-743. doi: 10.1016/j.ajhg.2013.04.008
162. Molina, D. P., Ariwodola, O. J., Weiner, J. L., Brunso-Bechtold, J. K., and Adams, M. M. (2013). Growth hormone and insulin-like growth factor-I alter hippocampal excitatory synaptic transmission in young and old rats. Age (Dordr.) 35, 1575-1587. doi: 10.1007/s11357-012-9460-4
163. Morice, E., Farley, S., Poirier, R., Dallerac, G., Chagneau, C., Pannetier, S., et al. (2013). Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome. Neurobiol. Dis. 58, 156-168. doi: 10.1016/j.nbd.2013.05.016
164. Muenke, M., Gripp, K. W., McDonald-McGinn, D. M., Gaudenz, K., Whitaker, L. A., Bartlett, S. P., et al. (1997). A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am. J. Hum. Genet. 60, 555-564.
165. Muinos-Gimeno, M., Guidi, M., Kagerbauer, B., Martin-Santos, R., Navines, R., Alonso, P., et al. (2009). Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum. Mutat. 30, 1062-1071. doi: 10.1002/humu.21005
166. Mutoh, T., Tachi, M., Yano, S., Mihara, T., and Yamamoto, H. (2005). Impairment of Trk-neurotrophin receptor by the serum of a patient with subacute sensory neuropathy. Arch. Neurol. 62, 1612-1615. doi: 10.1001/archneur.62.10.1612
167. Neale, B. M., Kou, Y., Liu, L., Ma'ayan, A., Samocha, K. E., Sabo, A., et al. (2012). Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242-245. doi: 10.1038/nature11011
168. Neves-Pereira, M., Cheung, J. K., Pasdar, A., Zhang, F., Breen, G., Yates, P., et al. (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 10, 208-212. doi: 10.1038/sj.mp.4001575
169. Neves-Pereira, M., Mundo, E., Muglia, P., King, N., Macciardi, F., and Kennedy, J. L. (2002). The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet. 71, 651-655. doi: 10.1086/342288
170. Nguyen, A., Rauch, T. A., Pfeifer, G. P., and Hu, V. W. (2010). Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J. 24, 3036-3051. doi: 10.1096/fj.10-154484
171. Niehrs, C. (2012). The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 13, 767-779. doi: 10.1038/nrm3470
172. Nikoletopoulou, V., Lickert, H., Frade, J. M., Rencurel, C., Giallonardo, P., Zhang, L., et al. (2010). Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 467, 59-63. doi: 10.1038/nature09336
173. Nishimune, H., Sanes, J. R., and Carlson, S. S. (2004). A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals. Nature 432, 580-587. doi: 10.1038/nature03112
174. Nishiyama, M., Skoultchi, A. I., and Nakayama, K. I. (2012). Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-beta-catenin signaling pathway. Mol. Cell. Biol. 32, 501-512. doi: 10.1128/MCB.06409-11
175. Nordstrom, U., Maier, E., Jessell, T. M., and Edlund, T. (2006). An early role for WNT signaling in specifying neural patterns of Cdx and Hox gene expression and motor neuron subtype identity. PLoS Biol. 4:e252. doi: 10.1371/journal.pbio.0040252
176. Novak, G., Seeman, P., and Tallerico, T. (2000). Schizophrenia: elevated mRNA for calcium-calmodulin-dependent protein kinase IIbeta in frontal cortex. Brain Res. Mol. Brain Res. 82, 95-100. doi: 10.1016/S0169-328X(00)00188-1
177. Nunez, A., Carro, E., and Torres-Aleman, I. (2003). Insulin-like growth factor I modifies electrophysiological properties of rat brain stem neurons. J. Neurophysiol. 89, 3008-3017. doi: 10.1152/jn.00089.2003
178. O'Brien, W. T., Harper, A. D., Jove, F., Woodgett, J. R., Maretto, S., Piccolo, S., et al. (2004). Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J. Neurosci. 24, 6791-6798. doi: 10.1523/JNEUROSCI.4753-03.2004
179. Okerlund, N. D., and Cheyette, B. N. (2011). Synaptic Wnt signaling-a contributor to major psychiatric disorders? J. Neurodev. Disord. 3, 162-174. doi: 10.1007/s11689-011-9083-6
180. O'Kusky, J., and Ye, P. (2012). Neurodevelopmental effects of insulin-like growth factor signaling. Front. Neuroendocrinol. 33, 230-251. doi: 10.1016/j.yfrne.2012.06.002
181. Orefice, L. L., Waterhouse, E. G., Partridge, J. G., Lalchandani, R. R., Vicini, S., and Xu, B. (2013). Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines. J. Neurosci. 33, 11618-11632. doi: 10.1523/JNEUROSCI.0012-13.2013
182. O'Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., et al. (2012a). Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338, 1619-1622. doi: 10.1126/science.1227764
183. O'Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., et al. (2012b). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246-250. doi: 10.1038/nature10989
184. Ortega, S., Ittmann, M., Tsang, S. H., Ehrlich, M., and Basilico, C. (1998). Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. U.S.A. 95, 5672-5677.
185. Paratcha, G., and Ledda, F. (2008). GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci. 31, 384-391. doi: 10.1016/j.tins.2008.05.003
186. Park, M., and Shen, K. (2012). WNTs in synapse formation and neuronal circuitry. EMBO J. 31, 2697-2704. doi: 10.1038/emboj.2012.145
187. Patzke, H., and Ernsberger, U. (2000). Expression of neurexin Ialpha splice variants in sympathetic neurons: selective changes during differentiation and in response to neurotrophins. Mol. Cell. Neurosci. 15, 561-572. doi: 10.1006/mcne.2000.0853
188. Perez, J. A., Clinton, S. M., Turner, C. A., Watson, S. J., and Akil, H. (2009). A new role for FGF2 as an endogenous inhibitor of anxiety. J. Neurosci. 29, 6379-6387. doi: 10.1523/JNEUROSCI.4829-08.2009
189. Perron, J. C., and Bixby, J. L. (1999). Distinct neurite outgrowth signaling pathways converge on ERK activation. Mol. Cell. Neurosci. 13, 362-378. doi: 10.1006/mcne.1999.0753
190. Petrik, D., Lagace, D. C., and Eisch, A. J. (2012). The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? Neuropharmacology 62, 21-34. doi: 10.1016/j.neuropharm.2011.09.003
191. Poduri, A., Chopra, S. S., Neilan, E. G., Elhosary, P. C., Kurian, M. A., Meyer, E., et al. (2012a). Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia 53, e146-e150. doi: 10.1111/j.1528-1167.2012.03538.x
192. Poduri, A., Evrony, G. D., Cai, X., Elhosary, P. C., Beroukhim, R., Lehtinen, M. K., et al. (2012b). Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 74, 41-48. doi: 10.1016/j.neuron.2012.03.010
193. Pollitt, A. Y., and Insall, R. H. (2009). WASP and SCAR/WAVE proteins: the drivers of actin assembly. J. Cell Sci. 122, 2575-2578. doi: 10.1242/jcs.023879
194. Poon, V. Y., Choi, S., and Park, M. (2013). Growth factors in synaptic function. Front. Synaptic Neurosci. 5:6. doi: 10.3389/fnsyn.2013.00006
195. Priolo, M., Lerone, M., Baffico, M., Baldi, M., Ravazzolo, R., Cama, A., et al. (2000). Pfeiffer syndrome type 2 associated with a single amino acid deletion in the FGFR2 gene. Clin. Genet. 58, 81-83. doi: 10.1034/j.1399-0004.2000.580116.x
196. Pyott, S. M., Tran, T. T., Leistritz, D. F., Pepin, M. G., Mendelsohn, N. J., Temme, R. T., et al. (2013). WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta. Am. J. Hum. Genet. 92, 590-597. doi: 10.1016/j.ajhg.2013.02.009
197. Qi, X. R., Zhao, J., Liu, J., Fang, H., Swaab, D. F., and Zhou, J. N. (2013). Abnormal Retinoid and TrkB Signaling in the Prefrontal Cortex in Mood Disorders. Cereb. Cortex. doi: 10.1093/cercor/bht203. [Epub ahead of print].
198. Quevedo, C., Alcazar, A., and Salinas, M. (2000). Two different signal transduction pathways are implicated in the regulation of initiation factor 2B activity in insulin-like growth factor-1-stimulated neuronal cells. J. Biol. Chem. 275, 19192-19197. doi: 10.1074/jbc.M000238200
199. Raile, K., Klammt, J., Schneider, A., Keller, A., Laue, S., Smith, R., et al. (2006). Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R. J. Clin. Endocrinol. Metab. 91, 2264-2271. doi: 10.1210/jc.2005-2146
200. Ramsey, M. M., Adams, M. M., Ariwodola, O. J., Sonntag, W. E., and Weiner, J. L. (2005). Functional characterization of des-IGF-1 action at excitatory synapses in the CA1 region of rat hippocampus. J. Neurophysiol. 94, 247-254. doi: 10.1152/jn.00768.2004
201. Ray, P., Devaux, Y., Stolz, D. B., Yarlagadda, M., Watkins, S. C., Lu, Y., et al. (2003). Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc. Natl. Acad. Sci. U.S.A. 100, 6098-6103. doi: 10.1073/pnas.1031851100
202. Reardon, W., Wilkes, D., Rutland, P., Pulleyn, L. J., Malcolm, S., Dean, J. C., et al. (1997). Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis. J. Med. Genet. 34, 632-636.
203. Reichardt, L. F. (2006). Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361, 1545-1564. doi: 10.1098/rstb.2006.1894
204. Ribases, M., Gratacos, M., Armengol, L., De Cid, R., Badia, A., Jimenez, L., et al. (2003). Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol. Psychiatry 8, 745-751. doi: 10.1038/sj.mp.4001281
205. Ribases, M., Gratacos, M., Fernandez-Aranda, F., Bellodi, L., Boni, C., Anderluh, M., et al. (2004). Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum. Mol. Genet. 13, 1205-1212. doi: 10.1093/hmg/ddh137
206. Rosch, H., Schweigreiter, R., Bonhoeffer, T., Barde, Y. A., and Korte, M. (2005). The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 102, 7362-7367. doi: 10.1073/pnas.0502460102
207. Rosso, S. B., and Inestrosa, N. C. (2013). WNT signaling in neuronal maturation and synaptogenesis. Front. Cell. Neurosci. 7:103. doi: 10.3389/fncel.2013.00103
208. Rosso, S. B., Sussman, D., Wynshaw-Boris, A., and Salinas, P. C. (2005). Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nat. Neurosci. 8, 34-42. doi: 10.1038/nn1374
209. Russo, E., Citraro, R., Constanti, A., and De Sarro, G. (2012). The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis. Mol. Neurobiol. 46, 662-681. doi: 10.1007/s12035-012-8314-5
210. Sanchez, M. M., Alagbe, O., Felger, J. C., Zhang, J., Graff, A. E., Grand, A. P., et al. (2007). Activated p38 MAPK is associated with decreased CSF 5-HIAA and increased maternal rejection during infancy in rhesus monkeys. Mol. Psychiatry 12, 895-897. doi: 10.1038/sj.mp.4002025
211. Sanhueza, M., McIntyre, C. C., and Lisman, J. E. (2007). Reversal of synaptic memory by Ca2+/calmodulin-dependent protein kinase II inhibitor. J. Neurosci. 27, 5190-5199. doi: 10.1523/JNEUROSCI.5049-06.2007
212. Sarachana, T., and Hu, V. W. (2013). Genome-wide identification of transcriptional targets of RORA reveals direct regulation of multiple genes associated with autism spectrum disorder. Mol. Autism 4, 14. doi: 10.1186/2040-2392-4-14
213. Scearce-Levie, K., Roberson, E. D., Gerstein, H., Cholfin, J. A., Mandiyan, V. S., Shah, N. M., et al. (2008). Abnormal social behaviors in mice lacking Fgf17. Genes Brain Behav. 7, 344-354. doi: 10.1111/j.1601-183X.2007.00357.x
214. Schmeisser, M. J., Baumann, B., Johannsen, S., Vindedal, G. F., Jensen, V., Hvalby, O. C., et al. (2012). IkappaB kinase/nuclear factor kappaB-dependent insulin-like growth factor 2 (Igf2) expression regulates synapse formation and spine maturation via Igf2 receptor signaling. J. Neurosci. 32, 5688-5703. doi: 10.1523/JNEUROSCI.0111-12.2012
215. Schmitt, A. M., Shi, J., Wolf, A. M., Lu, C. C., King, L. A., and Zou, Y. (2006). Wnt-Ryk signalling mediates medial-lateral retinotectal topographic mapping. Nature 439, 31-37. doi: 10.1038/nature04334
216. Schulz, J., Sundin, J., Leask, S., and Done, D. J. (2014). Risk of adult schizophrenia and its relationship to childhood IQ in the 1958 British birth cohort. Schizophr. Bull. 40, 143-151. doi: 10.1093/schbul/sbs157
217. Schumacher, J., Jamra, R. A., Becker, T., Ohlraun, S., Klopp, N., Binder, E. B., et al. (2005). Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 58, 307-314. doi: 10.1016/j.biopsych.2005.04.006
218. Sen, S., Duman, R., and Sanacora, G. (2008). Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 64, 527-532. doi: 10.1016/j.biopsych.2008.05.005
219. Sensi, A., Ceruti, S., Trevisi, P., Gualandi, F., Busi, M., Donati, I., et al. (2011). LAMM syndrome with middle ear dysplasia associated with compound heterozygosity for FGF3 mutations. Am. J. Med. Genet. A 155A, 1096-1101. doi: 10.1002/ajmg.a.33962
220. Shin, D. M., Korada, S., Raballo, R., Shashikant, C. S., Simeone, A., Taylor, J. R., et al. (2004). Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice. J. Neurosci. 24, 2247-2258. doi: 10.1523/JNEUROSCI.5285-03.2004
221. Shotelersuk, V., Ittiwut, C., Srivuthana, S., Mahatumarat, C., Lerdlum, S., and Wacharasindhu, S. (2002). Distinct craniofacial-skeletal-dermatological dysplasia in a patient with W290C mutation in FGFR2. Am. J. Med. Genet. 113, 4-8. doi: 10.1002/ajmg.10449
222. Smeyne, R. J., Klein, R., Schnapp, A., Long, L. K., Bryant, S., Lewin, A., et al. (1994). Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368, 246-249. doi: 10.1038/368246a0
223. Smoller, J. W., and Finn, C. T. (2003). Family, twin, and adoption studies of bipolar disorder. Am. J. Med. Genet. C Semin. Med. Genet. 123C, 48-58. doi: 10.1002/ajmg.c.20013
224. Squarzoni, P., Parveen, F., Zanetti, L., Ristoratore, F., and Spagnuolo, A. (2011). FGF/MAPK/Ets signaling renders pigment cell precursors competent to respond to Wnt signal by directly controlling Ci-Tcf transcription. Development 138, 1421-1432. doi: 10.1242/dev.057323
225. Squassina, A., Costa, M., Congiu, D., Manchia, M., Angius, A., Deiana, V., et al. (2013). Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. Pharmacol. Res. 73, 1-7. doi: 10.1016/j.phrs.2013.04.004
226. Stevens, H. E., Smith, K. M., Maragnoli, M. E., Fagel, D., Borok, E., Shanabrough, M., et al. (2010). Fgfr2 is required for the development of the medial prefrontal cortex and its connections with limbic circuits. J. Neurosci. 30, 5590-5602. doi: 10.1523/JNEUROSCI.5837-09.2010
227. Stockmeier, C. A., Mahajan, G. J., Konick, L. C., Overholser, J. C., Jurjus, G. J., Meltzer, H. Y., et al. (2004). Cellular changes in the postmortem hippocampus in major depression. Biol. Psychiatry 56, 640-650. doi: 10.1016/j.biopsych.2004.08.022
228. Stockmeier, C. A., and Rajkowska, G. (2004). Cellular abnormalities in depression: evidence from postmortem brain tissue. Dialogues Clin. Neurosci. 6, 185-197.
229. Stroppolo, A., Guinea, B., Tian, C., Sommer, J., and Ehrlich, M. E. (2001). Role of phosphatidylinositide 3-kinase in brain-derived neurotrophic factor-induced DARPP-32 expression in medium size spiny neurons in vitro. J. Neurochem. 79, 1027-1032. doi: 10.1046/j.1471-4159.2001.00651.x
230. Sudhof, T. C. (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-911. doi: 10.1038/nature07456
231. Sullivan, P. F., Magnusson, C., Reichenberg, A., Boman, M., Dalman, C., Davidson, M., et al. (2012). Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch. Gen. Psychiatry 69, 1099-1103. doi: 10.1001/archgenpsychiatry.2012.730
232. Tabatadze, N., Tomas, C., McGonigal, R., Lin, B., Schook, A., and Routtenberg, A. (2012). Wnt transmembrane signaling and long-term spatial memory. Hippocampus 22, 1228-1241. doi: 10.1002/hipo.20991
233. Talkowski, M. E., Rosenfeld, J. A., Blumenthal, I., Pillalamarri, V., Chiang, C., Heilbut, A., et al. (2012). Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149, 525-537. doi: 10.1016/j.cell.2012.03.028
234. Tartaglia, M., Valeri, S., Velardi, F., Di Rocco, C., and Battaglia, P. A. (1997). Trp290Cys mutation in exon IIIa of the fibroblast growth factor receptor 2 (FGFR2) gene is associated with Pfeiffer syndrome. Hum. Genet. 99, 602-606.
235. Tavormina, P. L., Bellus, G. A., Webster, M. K., Bamshad, M. J., Fraley, A. E., McIntosh, I., et al. (1999). A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. Am. J. Hum. Genet. 64, 722-731. doi: 10.1086/302275
236. Tekin, M., Hismi, B. O., Fitoz, S., Ozdag, H., Cengiz, F. B., Sirmaci, A., et al. (2007). Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia. Am. J. Hum. Genet. 80, 338-344. doi: 10.1086/510920
237. Tekin, M., Ozturkmen Akay, H., Fitoz, S., Birnbaum, S., Cengiz, F. B., Sennaroglu, L., et al. (2008). Homozygous FGF3 mutations result in congenital deafness with inner ear agenesis, microtia, and microdontia. Clin. Genet. 73, 554-565. doi: 10.1111/j.1399-0004.2008.01004.x
238. Teng, H. K., Teng, K. K., Lee, R., Wright, S., Tevar, S., Almeida, R. D., et al. (2005). ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 25, 5455-5463. doi: 10.1523/JNEUROSCI.5123-04.2005
239. Terauchi, A., Johnson-Venkatesh, E. M., Toth, A. B., Javed, D., Sutton, M. A., and Umemori, H. (2010). Distinct FGFs promote differentiation of excitatory and inhibitory synapses. Nature 465, 783-787. doi: 10.1038/nature09041
240. Terracciano, A., Tanaka, T., Sutin, A. R., Sanna, S., Deiana, B., Lai, S., et al. (2010). Genome-wide association scan of trait depression. Biol. Psychiatry 68, 811-817. doi: 10.1016/j.biopsych.2010.06.030
241. Terwisscha Van Scheltinga, A. F., Bakker, S. C., and Kahn, R. S. (2010). Fibroblast growth factors in schizophrenia. Schizophr. Bull. 36, 1157-1166. doi: 10.1093/schbul/sbp033
242. Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J. V., et al. (2006). Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. J. Clin. Invest. 116, 3060-3069. doi: 10.1172/JCI27341
243. Thompson Ray, M., Weickert, C. S., Wyatt, E., and Webster, M. J. (2011). Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J. Psychiatry Neurosci. 36, 195-203. doi: 10.1503/jpn.100048
244. Toydemir, R. M., Brassington, A. E., Bayrak-Toydemir, P., Krakowiak, P. A., Jorde, L. B., Whitby, F. G., et al. (2006). A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome. Am. J. Hum. Genet. 79, 935-941. doi: 10.1086/508433
245. Tripp, A., Oh, H., Guilloux, J. P., Martinowich, K., Lewis, D. A., and Sibille, E. (2012). Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am. J. Psychiatry 169, 1194-1202. doi: 10.1176/appi.ajp.2012.12020248
246. Tropea, D., Giacometti, E., Wilson, N. R., Beard, C., McCurry, C., Fu, D. D., et al. (2009). Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl. Acad. Sci. U.S.A. 106, 2029-2034. doi: 10.1073/pnas.0812394106
247. Tropea, D., Kreiman, G., Lyckman, A., Mukherjee, S., Yu, H., Horng, S., et al. (2006). Gene expression changes and molecular pathways mediating activity-dependent plasticity in visual cortex. Nat. Neurosci. 9, 660-668. doi: 10.1038/nn1689
248. Turner, C. A., Akil, H., Watson, S. J., and Evans, S. J. (2006). The fibroblast growth factor system and mood disorders. Biol. Psychiatry 59, 1128-1135. doi: 10.1016/j.biopsych.2006.02.026
249. Turner, C. A., Lewis, M. H., and King, M. A. (2003). Environmental enrichment: effects on stereotyped behavior and dendritic morphology. Dev. Psychobiol. 43, 20-27. doi: 10.1002/dev.10116
250. Turner, C. A., Watson, S. J., and Akil, H. (2012). The fibroblast growth factor family: neuromodulation of affective behavior. Neuron 76, 160-174. doi: 10.1016/j.neuron.2012.08.037
251. Uddin, L. Q., Supekar, K., Lynch, C. J., Khouzam, A., Phillips, J., Feinstein, C., et al. (2013). Salience network-based classification and prediction of symptom severity in children with autism. JAMA Psychiatry 70, 869-879. doi: 10.1001/jamapsychiatry.2013.104
252. Umemori, H. (2009). Weaving the neuronal net with target-derived fibroblast growth factors. Dev. Growth Differ. 51, 263-270. doi: 10.1111/j.1440-169X.2008.01079.x
253. Umemori, H., Linhoff, M. W., Ornitz, D. M., and Sanes, J. R. (2004). FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain. Cell 118, 257-270. doi: 10.1016/j.cell.2004.06.025
254. Utge, S. J., Soronen, P., Loukola, A., Kronholm, E., Ollila, H. M., Pirkola, S., et al. (2010). Systematic analysis of circadian genes in a population-based sample reveals association of TIMELESS with depression and sleep disturbance. PLoS ONE 5:e9259. doi: 10.1371/journal.pone.0009259
255. Uusitalo, M., Heikkila, M., and Vainio, S. (1999). Molecular genetic studies of Wnt signaling in the mouse. Exp. Cell Res. 253, 336-348. doi: 10.1006/excr.1999.4710
256. Van Amerongen, R., and Berns, A. (2006). Knockout mouse models to study Wnt signal transduction. Trends Genet. 22, 678-689. doi: 10.1016/j.tig.2006.10.001
257. Van Der Walt, J. M., Noureddine, M. A., Kittappa, R., Hauser, M. A., Scott, W. K., McKay, R., et al. (2004). Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am. J. Hum. Genet. 74, 1121-1127. doi: 10.1086/421052
258. Van Kesteren, R. E., Gagatek, J. S., Hagendorf, A., Gouwenberg, Y., Smit, A. B., and Syed, N. I. (2008). Postsynaptic expression of an epidermal growth factor receptor regulates cholinergic synapse formation between identified molluscan neurons. Eur. J. Neurosci. 27, 2043-2056. doi: 10.1111/j.1460-9568.2008.06189.x
259. Varela-Nallar, L., Alfaro, I. E., Serrano, F. G., Parodi, J., and Inestrosa, N. C. (2010). Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proc. Natl. Acad. Sci. U.S.A. 107, 21164-21169. doi: 10.1073/pnas.1010011107
260. Vernes, S. C., Newbury, D. F., Abrahams, B. S., Winchester, L., Nicod, J., Groszer, M., et al. (2008). A functional genetic link between distinct developmental language disorders. N. Engl. J. Med. 359, 2337-2345. doi: 10.1056/NEJMoa0802828
261. Vicario-Abejon, C., Collin, C., McKay, R. D., and Segal, M. (1998). Neurotrophins induce formation of functional excitatory and inhibitory synapses between cultured hippocampal neurons. J. Neurosci. 18, 7256-7271.
262. Vyssotski, A. L., Dell'omo, G., Poletaeva, I. I, Vyssotsk, D. L., Minichiello, L., Klein, R., et al. (2002). Long-term monitoring of hippocampus-dependent behavior in naturalistic settings: mutant mice lacking neurotrophin receptor TrkB in the forebrain show spatial learning but impaired behavioral flexibility. Hippocampus 12, 27-38. doi: 10.1002/hipo.10002
263. Wang, G., Van Der Walt, J. M., Mayhew, G., Li, Y. J., Zuchner, S., Scott, W. K., et al. (2008). Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am. J. Hum. Genet. 82, 283-289. doi: 10.1016/j.ajhg.2007.09.021
264. Wassink, T. H., Piven, J., Vieland, V. J., Huang, J., Swiderski, R. E., Pietila, J., et al. (2001). Evidence supporting WNT2 as an autism susceptibility gene. Am. J. Med. Genet. 105, 406-413. doi: 10.1002/ajmg.1401
265. Wei, F., Qiu, C. S., Liauw, J., Robinson, D. A., Ho, N., Chatila, T., et al. (2002). Calcium calmodulin-dependent protein kinase IV is required for fear memory. Nat. Neurosci. 5, 573-579. doi: 10.1038/nn855
266. Wider, C., Dachsel, J. C., Soto, A. I., Heckman, M. G., Diehl, N. N., Yue, M., et al. (2009). FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression. Mov. Disord. 24, 455-459. doi: 10.1002/mds.22442
267. Williams, E. L., and Casanova, M. F. (2011). Above genetics: lessons from cerebral development in autism. Transl. Neurosci. 2, 106-120. doi: 10.2478/s13380-011-0016-3
268. Williamson, W. R., and Hiesinger, P. R. (2008). Synaptic patterning by morphogen signaling. Sci. Signal. 1:pe20. doi: 10.1126/stke.118pe20
269. Wong, M. (2013). Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed. J. 36, 40-50. doi: 10.4103/2319-4170.110365
270. Wurdak, H., Ittner, L. M., Lang, K. S., Leveen, P., Suter, U., Fischer, J. A., et al. (2005). Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome. Genes Dev. 19, 530-535. doi: 10.1101/gad.317405
271. Wyss-Coray, T., Borrow, P., Brooker, M. J., and Mucke, L. (1997). Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice. J. Neuroimmunol. 77, 45-50.
272. Wyss-Coray, T., Lin, C., Yan, F., Yu, G. Q., Rohde, M., McConlogue, L., et al. (2001). TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612-618. doi: 10.1038/87945
273. Xie, C. W., Sayah, D., Chen, Q. S., Wei, W. Z., Smith, D., and Liu, X. (2000). Deficient long-term memory and long-lasting long-term potentiation in mice with a targeted deletion of neurotrophin-4 gene. Proc. Natl. Acad. Sci. U.S.A. 97, 8116-8121. doi: 10.1073/pnas.140204597
274. Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., et al. (2003). Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci. 6, 736-742. doi: 10.1038/nn1073
275. Yamanaka, Y., Kitano, A., Takao, K., Prasansuklab, A., Mushiroda, T., Yamazaki, K., et al. (2011). Inactivation of fibroblast growth factor binding protein 3 causes anxiety-related behaviors. Mol. Cell. Neurosci. 46, 200-212. doi: 10.1016/j.mcn.2010.09.003
276. Yilmazer-Hanke, D. M., Faber-Zuschratter, H., Blumcke, I., Bickel, M., Becker, A., Mawrin, C., et al. (2007). Axo-somatic inhibition of projection neurons in the lateral nucleus of amygdala in human temporal lobe epilepsy: an ultrastructural study. Exp. Brain Res. 177, 384-399. doi: 10.1007/s00221-006-0680-7
277. Yoshii, A., Murata, Y., Kim, J., Zhang, C., Shokat, K. M., and Constantine-Paton, M. (2011). TrkB and protein kinase Mzeta regulate synaptic localization of PSD-95 in developing cortex. J. Neurosci. 31, 11894-11904. doi: 10.1523/JNEUROSCI.2190-11.2011
278. Yu, H., Wang, D. D., Wang, Y., Liu, T., Lee, F. S., and Chen, Z. Y. (2012). Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J. Neurosci. 32, 4092-4101. doi: 10.1523/JNEUROSCI.5048-11.2012
279. Yu, H., Wang, Y., Pattwell, S., Jing, D., Liu, T., Zhang, Y., et al. (2009). Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory. J. Neurosci. 29, 4056-4064. doi: 10.1523/JNEUROSCI.5539-08.2009
280. Zeev, B. B., Bebbington, A., Ho, G., Leonard, H., De Klerk, N., Gak, E., et al. (2009). The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome. Neurology 72, 1242-1247. doi: 10.1212/01.wnl.0000345664.72220.6a
281. Zha, X. M., Bishop, J. F., Hansen, M. R., Victoria, L., Abbas, P. J., Mouradian, M. M., et al. (2001). BDNF synthesis in spiral ganglion neurons is constitutive and CREB-dependent. Hear. Res. 156, 53-68. doi: 10.1016/S0378-5955(01)00267-2
282. Zhang, X., Zhu, J., Yang, G. Y., Wang, Q. J., Qian, L., Chen, Y. M., et al. (2007). Dishevelled promotes axon differentiation by regulating atypical protein kinase C. Nat. Cell Biol. 9, 743-754. doi: 10.1038/ncb1603
283. Zintzaras, E. (2007). Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatr. Genet. 17, 69-75. doi: 10.1097/YPG.0b013e32801119da
284. Zorner, B., Wolfer, D. P., Brandis, D., Kretz, O., Zacher, C., Madani, R., et al. (2003). Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than "depressive." Biol. Psychiatry 54, 972-982. doi: 10.1016/S0006-3223(03)00418-9
285. Zuko, A., Kleijer, K. T., Oguro-Ando, A., Kas, M. J., Van Daalen, E., Van Der Zwaag, B., et al. (2013). Contactins in the neurobiology of autism. Eur. J. Pharmacol. 719, 63-74. doi: 10.1016/j.ejphar.2013.07.016